|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 12 (June 15), 1999:
pp. 4354-4364
Fusion of the ets Transcription Factor TEL to Jak2 Results in
Constitutive Jak-Stat Signaling
Jen M.-Y. Ho,
Bryan K. Beattie,
Jeremy A. Squire,
David A. Frank, and
Dwayne L. Barber
From the Division of Cellular and Molecular Biology, Ontario Cancer
Institute, Toronto, Ontario, Canada; the Department of Laboratory
Medicine and Pathobiology, Toronto Hospital, Toronto, Ontario, Canada;
the Departments of Medical Biophysics and Laboratory Medicine and
Pathobiology, University of Toronto, Toronto, Ontario, Canada; and the
Dana-Farber Cancer Institute, Boston, MA.
To study constitutive Janus kinase signaling, chimeric
proteins were generated between the pointed domain of the ets
transcription factor TEL and the cytosolic tyrosine kinase Jak2. The
effects of these proteins on interleukin-3 (IL-3)-dependent
proliferation of the hematopoietic cell line, Ba/F3, were studied.
Fusion of TEL to the functional kinase (JH1) domain of Jak2 resulted in conversion of Ba/F3 cells to factor-independence. Importantly, fusion
of TEL to the Jak2 pseudokinase (JH2) domain or a kinase-inactive Jak2
JH1 domain had no effect on IL-3-dependent proliferation of Ba/F3
cells. Active TEL-Jak2 constructs (consisting of either Jak2 JH1 or
Jak2 JH2+JH1 domain fusions) were constitutively
tyrosine-phosphorylated but did not affect phosphorylation of
endogeneous Jak1, Jak2, or Jak3. TEL-Jak2 activation resulted in the
constitutive tyrosine phosphorylation of Stat1, Stat3, and Stat5 as
determined by detection of phosphorylation using activation-specific
antibodies and by binding of each protein to a preferential GAS
sequence in electrophoretic mobility shift assays. Elucidation of
signaling events downstream of TEL-Jak2 activation may provide insight
into the mechanism of leukemogenesis mediated by this oncogenic fusion protein.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. W. Kim, H. K. Chung, K. C. Park, J. H. Hwang, Y. S. Jo, J. Chung, D. V. Kalvakolanu, N. Resta, and M. Shong
Tumor Suppressor LKB1 Inhibits Activation of Signal Transducer and Activator of Transcription 3 (STAT3) by Thyroid Oncogenic Tyrosine Kinase Rearranged in Transformation (RET)/Papillary Thyroid Carcinoma (PTC)
Mol. Endocrinol.,
December 1, 2007;
21(12):
3039 - 3049.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Kennedy, F. Barabe, B. J. Patterson, J. Bayani, J. A. Squire, D. L. Barber, and J. E. Dick
Expression of TEL-JAK2 in primary human hematopoietic cells drives erythropoietin-independent erythropoiesis and induces myelofibrosis in vivo
PNAS,
November 7, 2006;
103(45):
16930 - 16935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. K. Lee, K. Man, R. T.P. Poon, C. M. Lo, A. P. Yuen, I. O. Ng, K. T. Ng, W. Leonard, and S. T. Fan
Signal Transducers and Activators of Transcription 5b Activation Enhances Hepatocellular Carcinoma Aggressiveness through Induction of Epithelial-Mesenchymal Transition.
Cancer Res.,
October 15, 2006;
66(20):
9948 - 9956.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Zhuang, Y. Qiu, S. J. Haque, and F. Dong
Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: involvement of SOCS3 and SOCS1
J. Leukoc. Biol.,
October 1, 2005;
78(4):
1008 - 1015.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Moucadel and S. N. Constantinescu
Differential STAT5 Signaling by Ligand-dependent and Constitutively Active Cytokine Receptors
J. Biol. Chem.,
April 8, 2005;
280(14):
13364 - 13373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Li, T. J. Ahonen, K. Alanen, J. Xie, M. J. LeBaron, T. G. Pretlow, E. L. Ealley, Y. Zhang, M. Nurmi, B. Singh, et al.
Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade
Cancer Res.,
July 15, 2004;
64(14):
4774 - 4782.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. O. Flowers, H. M. Johnson, M. G. Mujtaba, M. R. Ellis, S. M. I. Haider, and P. S. Subramaniam
Characterization of a Peptide Inhibitor of Janus Kinase 2 That Mimics Suppressor of Cytokine Signaling 1 Function
J. Immunol.,
June 15, 2004;
172(12):
7510 - 7518.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Guo, E. Mascareno, and M. A. Q. Siddiqui
Distinct Components of Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway Mediate the Regulation of Systemic and Tissue Localized Renin-Angiotensin System
Mol. Endocrinol.,
April 1, 2004;
18(4):
1033 - 1041.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Heath and N. C. P. Cross
Critical Role of STAT5 Activation in Transformation Mediated by ZNF198-FGFR1
J. Biol. Chem.,
February 20, 2004;
279(8):
6666 - 6673.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Benekli, M. R. Baer, H. Baumann, and M. Wetzler
Signal transducer and activator of transcription proteins in leukemias
Blood,
April 15, 2003;
101(8):
2940 - 2954.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M.-Y. Ho, M. H.-H. Nguyen, J. K. Dierov, K. M. Badger, B. K. Beattie, P. Tartaro, R. Haq, B. W. Zanke, M. P. Carroll, and D. L. Barber
TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways
Blood,
July 30, 2002;
100(4):
1438 - 1448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Drachman, Y. Miyakawa, J. N. Luthi, D. D. Dahlen, A. Raney, A. E. Geddis, and K. Kaushansky
Studies with Chimeric Mpl/JAK2 Receptors Indicate That Both JAK2 and the Membrane-proximal Domain of Mpl Are Required for Cellular Proliferation
J. Biol. Chem.,
June 21, 2002;
277(26):
23544 - 23553.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Sternberg, M. H. Tomasson, M. Carroll, D. P. Curley, G. Barker, M. Caprio, A. Wilbanks, A. Kazlauskas, and D. G. Gilliland
The TEL/PDGFbeta R fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways
Blood,
December 1, 2001;
98(12):
3390 - 3397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Frantsve, J. Schwaller, D. W. Sternberg, J. Kutok, and D. G. Gilliland
Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation
Mol. Cell. Biol.,
May 15, 2001;
21(10):
3547 - 3557.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. L. Barber, B. K. Beattie, J. M. Mason, M. H.-H. Nguyen, M. Yoakim, B. G. Neel, A. D. D'Andrea, and D. A. Frank
A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation
Blood,
April 15, 2001;
97(8):
2230 - 2237.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J O'Shea, R. Visconti, T. P Cheng, and M. Gadina
Jaks and Stats as therapeutic targets
Ann Rheum Dis,
November 1, 2000;
59(90001):
i115 - 118.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Gesbert and J. D. Griffin
Bcr/Abl activates transcription of the Bcl-X gene through STAT5
Blood,
September 15, 2000;
96(6):
2269 - 2276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Lacronique, A. Boureux, R. Monni, S. Dumon, M. Mauchauffe, P. Mayeux, F. Gouilleux, R. Berger, S. Gisselbrecht, J. Ghysdael, et al.
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells
Blood,
March 15, 2000;
95(6):
2076 - 2083.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Ward, I. Touw, and A. Yoshimura
The Jak-Stat pathway in normal and perturbed hematopoiesis
Blood,
January 1, 2000;
95(1):
19 - 29.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H.-H. Nguyen, J. M.-Y. Ho, B. K. Beattie, and D. L. Barber
TEL-JAK2 Mediates Constitutive Activation of the Phosphatidylinositol 3'-Kinase/Protein Kinase B Signaling Pathway
J. Biol. Chem.,
August 24, 2001;
276(35):
32704 - 32713.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
